Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Quest Diagnostics Inc (DGX)  
$136.94 1.30 (0.96%) as of 4:30 Tue 5/7


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 134,770,000
Market Cap: 18.46(B)
Last Volume: 637,785 Avg Vol: 1,177,170
52 Week Range: $120.62 - $144.92
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  724
Guru Rank Value     : 1.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 18,097 18,097 18,097 536,229
Total Sell Value $2,309,019 $2,309,019 $2,309,019 $75,325,755
Total People Sold 4 4 4 7
Total Sell Transactions 7 7 7 25
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 1532
  Page 10 of 62  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-03-09 4 D $115.42 $486,726 D/D (4,217) 45,726     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-03-09 4 A $115.42 $1,130,077 D/D 9,791 49,943     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2021-03-09 4 D $115.42 $78,947 D/D (684) 26,802     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2021-03-09 4 A $115.42 $217,451 D/D 1,884 27,485     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2021-03-09 4 D $115.42 $2,987,878 D/D (25,887) 284,427     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2021-03-09 4 A $115.42 $6,736,835 D/D 58,368 310,314     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-03-09 4 D $115.42 $711,564 D/D (6,165) 30,250     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-03-09 4 A $115.42 $1,521,351 D/D 13,181 36,394     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2021-03-09 4 D $115.42 $584,718 D/D (5,066) 77,265     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2021-03-09 4 A $115.42 $1,304,131 D/D 11,299 82,331     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2021-03-09 4 D $115.42 $961,910 D/D (8,334) 49,931     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2021-03-09 4 A $115.42 $1,912,509 D/D 16,570 58,265     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2021-03-09 4 D $115.42 $739,034 D/D (6,403) 88,792     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2021-03-09 4 A $115.42 $1,999,305 D/D 17,322 95,195     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-02-25 4 AS $115.49 $92,507 D/D (801) 40,152 17%     
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-02-24 4 D $121.19 $74,047 D/D (611) 23,213     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2021-02-24 4 D $121.19 $63,504 D/D (524) 71,032     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2021-02-24 4 D $121.19 $402,230 D/D (3,319) 251,946     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2021-02-24 4 D $121.19 $12,483 D/D (103) 25,601     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2021-02-24 4 D $121.19 $97,679 D/D (806) 41,695     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-02-24 4 AS $116.95 $138,937 D/D (1,188) 40,953 15%     
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-02-24 4 D $121.19 $55,141 D/D (455) 42,141     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2021-02-24 4 D $121.19 $65,564 D/D (541) 77,873     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-02-23 4 D $121.15 $123,210 D/D (1,017) 23,824     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2021-02-23 4 D $121.15 $96,435 D/D (796) 71,556     -
  1532 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 62
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us